ID: ALA612091

Max Phase: Preclinical

Molecular Formula: C13H21NO

Molecular Weight: 207.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CCCCC1/C=C1\CCCCC1=O

Standard InChI:  InChI=1S/C13H21NO/c1-14-9-5-4-7-12(14)10-11-6-2-3-8-13(11)15/h10,12H,2-9H2,1H3/b11-10+

Standard InChI Key:  DEYDTFXUHYVURR-ZHACJKMWSA-N

Associated Targets(non-human)

Neuronal acetylcholine receptor 756 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 207.32Molecular Weight (Monoisotopic): 207.1623AlogP: 2.54#Rotatable Bonds: 1
Polar Surface Area: 20.31Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.19CX LogP: 2.66CX LogD: 1.81
Aromatic Rings: 0Heavy Atoms: 15QED Weighted: 0.62Np Likeness Score: 0.21

References

1. Villeneuve G, Cécyre D, Lejeune H, Drouin M, Lan R, Quirion R..  (2003)  Rigidified acetylcholine mimics: conformational requirements for binding to neuronal nicotinic receptors.,  13  (21): [PMID:14552793] [10.1016/s0960-894x(03)00728-5]

Source